WHITE HOUSE SURGERY
1 FAIRFAX RISE, SHEFFIELD
Stroke 12
The % of patients with a stroke shown to be non-haemorrhagic, or a history of TIA, who have a record that an anti-platelet agent (aspirin, clopidogrel, dipyridamole or a combination), or an anti-coagulant is being taken (unless a contraindication or side-effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| STROKE 9 | 2005 | 84 | 94 | 89.4% | |
| STROKE 9 | 2006 | 99 | 108 | 91.7% | |
| Stroke 12 | 2007 | 96 | 106 | 90.6% | |
| Stroke 12 | 2008 | 99 | 105 | 94.3% | |
| Stroke 12 | 2009 | 100 | 110 | 90.9% | |
| Stroke 12 | 2010 | 108 | 114 | 94.7% | |
| STROKE 12 | 2011 | 106 | 115 | 92.2% | |
| STROKE 12 | 2012 | 104 | 112 | 92.9% | |
| STROKE 12 | 2013 | 104 | 111 | 93.7% | |
| STIA007 | 2014 | 99 | 101 | 98.0% | |
| STIA007 | 2015 | 102 | 104 | 98.1% | |
| STIA007 | 2016 | 89 | 91 | 97.8% | |
| STIA007 | 2017 | 82 | 84 | 97.6% | |
| STIA007 | 2018 | 74 | 74 | 100.0% | |
| STIA007 | 2019 | 80 | 80 | 100.0% | |
| STIA007 | 2020 | 76 | 77 | 98.7% | |
| STIA007 | 2021 | 75 | 81 | 92.6% | |
| STIA007 | 2022 | 88 | 95 | 92.6% | |
| STIA007 | 2023 | 100 | 103 | 97.1% |
